@article{6cbbeebabc0140d6a19bc2bc3f33e8b1,
title = "Treatment Guidance for Patients With Lung Cancer During the Coronavirus 2019 Pandemic",
keywords = "CELL, CISPLATIN, COVID-19, ETOPOSIDE, Lung cancer, PHASE-III, Patient care, RADIATION, SARS-CoV-2, CHINA, WUHAN",
author = "Dingemans, {Anne-Marie C.} and Soo, {Ross A.} and Jazieh, {Abdul Rahman} and Rice, {Shawn J.} and Kim, {Young Tae} and Teo, {Lynette L. S.} and Warren, {Graham W.} and Shu-Yuan Xiao and Smit, {Egbert F.} and Aerts, {Joachim G.} and Yoon, {Soon Ho} and Giulia Veronesi and {De Cobelli}, Francesco and Ramalingam, {Suresh S.} and Garassino, {Marina C.} and Wynes, {Murry W.} and Madhusmita Behera and John Haanen and Shun Lu and Solange Peters and Myung-Ju Ahn and Scagliotti, {Giorgio V.} and Adjei, {Alex A.} and Belani, {Chandra P.}",
year = "2020",
month = jul,
doi = "10.1016/j.jtho.2020.05.001",
language = "English",
volume = "15",
pages = "1119--1136",
journal = "Journal of Thoracic Oncology",
issn = "1556-0864",
publisher = "Elsevier Science",
number = "7",
}